Mitchell Sinkler & Starr’s Edwards Lifesciences EW Stock Holding History

Mitchell Sinkler & Starr’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$246K	Sell	2,850 -50	-2%	-$4.44K	0.1%	144
2026 Q2	$262K	Hold	2,900	–	–	0.11%	138
2026 Q1	$232K	Hold	2,900	–	–	0.11%	137
2025 Q4	$247K	Buy	2,900 +175	+6%	+$14.4K	0.11%	131
2025 Q3	$212K	Sell	2,725 -75	-3%	-$5.86K	0.1%	139
2025 Q2	$219K	Hold	2,800	–	–	0.1%	136
2025 Q1	$203K	Hold	2,800	–	–	0.06%	151
2024 Q4	$207K	Buy	+2,800	New	+$196K	0.06%	154
2024 Q3	–	Sell	-2,800	Closed	-$240K	–	191
2024 Q2	$240K	Buy	+2,800	New	+$248K	0.06%	140
2023 Q3	–	Sell	-2,800	Closed	-$264K	–	109
2023 Q2	$264K	Hold	2,800	–	–	0.08%	127
2023 Q1	$232K	Hold	2,800	–	–	0.07%	133
2022 Q4	$209K	Buy	+2,800	New	+$216K	0.07%	136
2021 Q1	–	Sell	-3,750	Closed	-$342K	–	102
2020 Q4	$342K	Hold	3,750	–	–	0.33%	76
2020 Q3	$299K	Hold	3,750	–	–	0.3%	78
2020 Q2	$259K	Buy	+3,750	New	+$266K	0.29%	83
2020 Q1	–	Sell	-3,150	Closed	-$245K	–	97
2019 Q4	$245K	Buy	+3,150	New	+$246K	0.26%	89

Other funds holding EW

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Mitchell Sinkler & Starr's EW Position: Q3 2026 in Review

Mitchell Sinkler & Starr reduced its Edwards Lifesciences (EW) stake by 1.7% in Q3 2026, selling an estimated $4.44K and leaving 2,850 shares worth $246K. The position accounts for 0.1% of the portfolio, ranked #144.

Mitchell Sinkler & Starr first reported a position in EW in Q4 2019 and has held it in 16 quarters since. The position peaked at $342K in Q4 2020. 303 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Mitchell Sinkler & Starr held 2,850 shares of Edwards Lifesciences worth $246K as of Q3 2026.
Mitchell Sinkler & Starr sold 50 Edwards Lifesciences shares in Q3 2026, an estimated $4.44K.
Edwards Lifesciences made up 0.1% of Mitchell Sinkler & Starr's portfolio in Q3 2026, its #144 holding.
Mitchell Sinkler & Starr first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 16 quarters since.
Mitchell Sinkler & Starr's Edwards Lifesciences position peaked at $342K in Q4 2020.
303 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Mitchell Sinkler & Starr's 13F filing for Q3 2026, filed 13 Oct 2026.